tisagenlecleucel,ibrutinib
novartis,abbvie,janssen
['tisagenlecleucel', 'lymphoma', 'tarmac', 'mantle,(-dismantle)', 'tisa-cel', ' ibru']
time limited ibrutinib added to anti-cd19 car-t product tisa-cel in pts with r/r mantle cell lymphoma showed high rates of durable response irrespective of prior btk exposure and tp53 status. excited to see longer follow up results in this r/r mcl population #ash22 
Heme/Onc Fellow @ClevelandClinic| Proud @PittTweet, @WakeForestMed and @OhioStateIMRes Alum| Opinions Are My Own| Most Tweets Will Involve Soccer